Novo Nordisk is under investor pressure for transparency regarding their obesity drug CagriSema, after trial results disappointed. Patients report weight loss but side effects like nausea. Investors ...

Tougher regulations to ensure drugs such as Wegovy and Mounjaro only go to those with a true clinical need have been ...

The pharmacy regulator is working with other bodies to jointly tackle inappropriate advertising and promotions of the drugs ...

Gov. Greg Abbott has named raising teacher pay and school vouchers as a priority for this legislative session. A bill could ...